UCLA Jonsson Comprehensive Cancer Center | Strategic Alliance Partners

Latest from UCLA Jonsson Comprehensive Cancer Center

Dr. Boutros on the Utility of Genetic Testing in Prostate Cancer

November 24, 2020

Video

Paul C. Boutros, PhD, MBA, discusses the utility of genetic testing in prostate cancer.

Dr. Salani on Therapeutic Advances in Endometrial Cancer

November 02, 2020

Video

Ritu Salani, MD, MBA, discusses therapeutic advances in endometrial cancer.

More Clinical Trials Needed to Overcome PARP Inhibitor Resistance in Ovarian Cancer

November 02, 2020

Article

Gottfried E. Konecny, MD, discusses potential strategies to overcome PARP resistance, future combinations with PARP inhibitors, and other unmet needs in ovarian cancer.

Shaping a New Future With Novel Therapeutics in Gynecologic Cancers

October 31, 2020

Article

Ritu Salani, MD, MBA, discusses updates to PARP inhibition and FRα-targeting agents in ovarian cancer, the role of bevacizumab across all lines of ovarian cancer therapy, and immunotherapy highlights in cervical and endometrial cancer.

Frontline Maintenance Therapy Transforms Advanced Ovarian Cancer With PARP Inhibitors

October 30, 2020

Article

Mae Zakhour, MD, discusses the rise of PARP inhibitors as frontline maintenance therapy in advanced ovarian cancer and the key data that supported these regulatory decisions.

Dr. Boutros on Processes That Predict Lethality in Prostate Cancer

October 26, 2020

Video

Paul C. Boutros, PhD, MBA, discusses processes that predict disease lethality in men with prostate cancer.